|  | Cancer | Skin Cancer

Non-Melanoma Skin Cancer Statistics: Incidence, Underreporting & Global Burden

Correction: Non-melanoma skin cancers (NMSC)—basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)—are recorded in cancer statistics, but systematic underreporting obscures true incidence.

Epidemiologic Reality

  • Most common cancer globally: NMSC exceeds all other cancers combined.
  • Estimated annual cases: 5–7 million worldwide (BCC ~75%, SCC ~25%).
  • Underreporting drivers:
  1. Mandatory reporting exemptions in many registries (low mortality).
  2. Outpatient treatment (destruction, excision) without pathology registry linkage.
  3. Multiple primaries per patient counted as single case.
  4. No centralized registry in many countries.

Regional Variation

  • Highest: Australia, New Zealand, US (white populations), South Africa.
  • Rising: Europe, Latin America, Asia (aging, UV exposure, detection).
  • Mortality: Low (~0.5% of cancer deaths) but significant morbidity and cost.

Risk Factors

  • Cumulative UV exposure (occupational, recreational).
  • Fair skin (Fitzpatrick I–II), immunosuppression.
  • Prior NMSC (35–50% 5-year recurrence risk).
  • Genetic syndromes (xeroderma pigmentosum, basal cell nevus syndrome).

Public Health Implication

True NMSC burden is 2–5× reported rates. Prevention (UV protection, nicotinamide for high-risk) and registry reform are priorities. BCC rarely metastasizes; SCC has 2–5% metastatic potential—early detection critical.

Skin Cancer - Related Articles